Lates News

Every Economy AI Briefing, China Post Securities released a research report on May 21, giving Fu Medical (301087.SZ) a buy rating. The main reasons for the rating include: 1) The company focuses on home medical care, with impressive performance of rehabilitation aids products; 2) The company focuses on core categories to conduct technological breakthroughs, continuously improves R&D efficiency, and achieves rapid transformation of innovative results. (Daily Economic News)